ECA - Ensaio clínico aleatorizado | MBE - Medicina baseada na evidência | RS - Revisão Sistemática
RS de ECA
Endocrinologia
Gastroenterologia
MBE & Meta-investigação
Neurologia
Oncologia
ECA
Cirurgia
COVID-19
Ad5-nCov (recombinant adenovirus vaccine) in 18 years and older | Lancet
Heterologous COVID-19 vaccination (Com-COV2 NIT) - The Lancet
Third dose (booster) following ChAdOx1 or BNT, Lancet | ISBE
Immunogenicity and safety of a third dose of CoronaVac - Lancet
Ab 4 wks after Heterologous booster in Kidney Transplant | JAMA IM
Early Remdesivir Progression Prevention to Severe Covid in Outpat | NEJM
Molnupiravir in Nonvaccinated Nonhospitalized Patients | NEJM
nAB for Hospitalized Patients According to Baseline Ag Levels | AIM
Two nAB, sotrovimab and BRII-196 plus BRII-198 (TICO) - The Lancet
Lenzilumab in hospitalised COVID-19 pneumonia (LIVE-AIR) | Editorial
Namilumab or infliximab vs SoC, proof of concept (CATALYST) - The Lancet
High-Flow Oxygen Therapy vs COT on IMV and Recovery in Severe COVID
Rivaroxaban for post-discharge thromboprophylaxis (MICHELLE) - Lancet
Doente crítico
Gastroenterologia
Geral
Geriatria & Paliativos
Hematologia
Imuno-mediado
Infecciologia, Microbiologia & Antibióticos
Neurologia
Oncologia
PORT vs no-PORT in completely resected NSCLC N2 (Lung ART) - Lancet
Nivolumab vs sorafenib in advanced hepatocellular carcinoma - The Lancet
GnRHa in Premenopausal Women in Chemotherapy | JAMA Oncology
Telephone based management of AE during CT for early stage breast cancer
KdD vs Kd against relapsed or refractory multiple myeloma (CANDOR)
Second-Line Tisagenlecleucel or SC in Aggressive B-Cell Lymphoma - NEJM
Axicabtagene Ciloleucel as Second-Line Therapy for LBCL - NEJM
Ortopedia & MFR
Pneumologia
Psiquiatria
GUIDELINES
REVISÃO DE OBSERVACIONAIS (com ou sem ECA’s)
COVID-19
Doente Crítico
Endocrinologia
MBE & Meta-investigação
Oncologia
PROSPECTIVOS
Cardiovascular
Cirurgia
COVID-19
T-cell and Ab after first BNT162b2 vaccine dose in previously infected
CoronaVac and seropositivity in autoimmune RD - Lancet Rheumatology
Hybrid immunity vs vaccine-induced immunity in rheumatic diseases
Viral characteristics between alpha and delta / vaccinated and unvaccinated
Ab Response and Breakthrough Infection in Patients w/ Dialysis | AIM
Ab Titers Before and After a Third Dose of BNT162b2 Vaccine in Older Adults
BNT162b2 mRNA booster in actively treated patients w/ cancer - Lancet
COVID-19 Vaccine Type and AEs Following Vaccination | JAMA Network
SARS-CoV-2 antigen-detecting rapid tests for the delta and other variants
Assessment of Preferences for Telehealth in Post–COVID-19 Health Care
Geriatria & Paliativos
Imagiologia
MBE & Meta-investigação
Nefrologia
Neurologia
Oncologia
Pneumologia
RETROSPECTIVOS
Cardiovascular
Cirurgia
COVID-19
Severity of Delta vs Beta Variant in Qatar | JAMA Internal Medicine
Omicron in South Africa - admissions and vaccine effectiveness | NEJM
Outcomes in South Africa during Omicron Wave vs. Other Waves | JAMA NO
Moderna, Pfizer and Janssen effectiveness against delta with time
Natural Immunity against reinfection with Alpha and Beta Variants
Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals
Effectiveness of mRNA Vaccine Against Infection in Older Male | JAMA NO
mRNA Vaccination Effectiveness Against Infection or Death in Elderly | AIM
BNT162b2 Booster and Mortality Due to Covid-19 in Israel | NEJM
BNT162b2 Booster in Long-term Care Facilities in Israel | NEJM
Protection of BNT162b2 Booster across Age Groups in Israel | NEJM
Third BNT162b2 Vaccination Neutralization of beta, delta and omicron | NEJM
Testing Among Residential College Students in Connecticut | JAMA NO
Invasive pneumococcal disease after three COVID-19 waves in England
Myocarditis after Pfizer Vaccine in a Large Healthcare Organization (Israel)
Doente crítico
Endocrinologia
Gastroenterologia
Hematologia
Imuno-mediado
Infecciologia, Microbiologia & Antibióticos
MBE & Meta-investigação
Nefrologia
Neurologia
Oncologia
Ortopedia & MFR
Pneumologia
Psiquiatria
CASO CLÍNICO
ECG
Músculo-esquelético - Severe Polyarthralgia After Kidney Transplant
ANÁLISE ECONÓMICA / CUSTO-EFECTIVIDADE / CUSTO-UTILIDADE
OUTROS
Cardiovascular
COVID-19
COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed
Bureaucracy has created a mess for Novavax volunteers like me
Covid-19: Antibody boost after third dose varies greatly by COV-BOOST
Vaccine strategies must focus on severe disease and global equity - Lancet
Risk Heterogeneity and the Illusion of Waning Vaccine Efficacy | AIM
Doente crítico
Gastroenterologia
Geral
Less is more (JAMA)
MBE & Meta-investigação
Neurologia
Ortopedia & MFR
Oncologia
Pneumologia
POCUS
FOAMed
Cardiovascular
COVID-19
Doente crítico
Geral
Infecciologia, Microbiologia & Antibióticos
Nefrologia
Neurologia
Comments